Back
Kymera Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
77
KYMR
Kymera Therapeutics, Inc.
Last Price:
$83.54
Seasonality Move:
-2.06%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and KYMR is experiencing slight buying pressure.
Kymera Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.68 | Sell |
| 20-day SMA: | 77.29 | Buy |
| 50-day SMA: | 67.68 | Buy |
| 200-day SMA: | 46.9 | Buy |
| 8-day EMA: | 83.13 | Buy |
| 20-day EMA: | 78.46 | Buy |
| 50-day EMA: | 69.59 | Buy |
| 200-day EMA: | 52.84 | Buy |
Kymera Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.49 | Buy |
| Relative Strength Index (14 RSI): | 61.45 | Buy |
| Chaikin Money Flow: | 133015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.29 - 85.29) | Buy |
| Bollinger Bands (100): | (43.96 - 70.76) | Buy |
Kymera Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics, Inc. Stock
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 84.35 while KYMR 8-day simple moving average is 84.68, which is a Sell signal.
-
The stock price of KYMR is 84.35 while Kymera Therapeutics, Inc. 20-day SMA is 77.29, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day simple moving average is 67.68 while KYMR share price is 84.35, making it a Buy technically.
-
KYMR stock price is 84.35 and Kymera Therapeutics, Inc. 200-day simple moving average is 46.90, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
77
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy or a Sell?
-
Kymera Therapeutics, Inc. stock is rated a BuyThe current Kymera Therapeutics, Inc. [KYMR] share price is $84.35. The Score for KYMR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics, Inc. Stock Info
Market Cap:
6.1B
Price in USD:
84.35
Share Volume:
804.4K
Kymera Therapeutics, Inc. 52-Week Range
52-Week High:
103.00
52-Week Low:
19.45
Buy
77
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Kymera Therapeutics, Inc. Share Price Forecast
-
What is the Kymera Therapeutics, Inc. stock price today?The Kymera Therapeutics, Inc. stock price is 84.35 USD today.
-
Will KYMR stock go up or go down?Kymera Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Kymera Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics, Inc. is not overvalued.
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 84.35 while KYMR 8-day exponential moving average is 83.13, which is a Buy signal.
-
The stock price of KYMR is 84.35 while Kymera Therapeutics, Inc. 20-day EMA is 78.46, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day exponential moving average is 69.59 while KYMR share price is 84.35, making it a Buy technically.
-
KYMR stock price is 84.35 and Kymera Therapeutics, Inc. 200-day simple moving average is 52.84, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics, Inc.
Is Kymera Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.62 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Kymera Therapeutics, Inc.
Should I short Kymera Therapeutics, Inc. stock?
-
KYMR Moving Average Covergence Divergence (MACD) indicator is 5.49, suggesting Kymera Therapeutics, Inc. is a Buy
-
Kymera Therapeutics, Inc. Relative Strength Index (RSI) is 61.45, which suggest Kymera Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Kymera Therapeutics, Inc. is (64.29 - 85.29), which suggest Kymera Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Kymera Therapeutics, Inc. is (43.96 - 70.76), which suggest Kymera Therapeutics, Inc. is a Buy
* Kymera Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.